Tidl Full Body Pain Relief Cryotherapy Spray.

Description

The drug is formulated as a tablet containing the active ingredient insert active ingredient name here. The tablet exhibits insert physical characteristics, e.g., color, shape, size. Inactive ingredients include list of inactive ingredients.

Uses and Indications

This drug is indicated for the temporary relief of minor aches and pains associated with muscles and joints, including those related to arthritis, simple backache, strains, and sprains.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Adults and children 12 years of age and older should apply the medication to the affected area no more than 3 to 4 times daily. For children under 12 years of age, it is recommended to consult a physician prior to use to determine appropriate dosing and administration.

Contraindications

Use of this product is contraindicated in the following situations:

Smoking or exposure to heat or flame during use may pose a significant risk of fire or explosion.

Contact with the eyes or mucous membranes should be strictly avoided to prevent irritation or injury.

Application to wounds, damaged skin, or irritated skin is contraindicated due to the potential for adverse reactions.

Bandaging the area after application is not recommended, as it may alter the product's effectiveness or increase the risk of side effects.

Additionally, the use of heating pads or devices in conjunction with this product is contraindicated, as it may lead to increased absorption and potential toxicity.

Warnings and Precautions

For external use only. It is imperative to avoid contact with the eyes or mucous membranes. The product should not be applied to wounds, damaged skin, or irritated skin. Additionally, it is advised not to bandage the area after application. Healthcare professionals should instruct patients to wash their hands thoroughly with cool water after use. The use of heating pads or devices in conjunction with this product is contraindicated.

In the event of accidental ingestion, immediate medical assistance should be sought, or the individual should contact a Poison Control Center without delay.

Patients should be advised to discontinue use and consult their healthcare provider if their condition worsens, if symptoms persist for more than 7 days, or if symptoms resolve and then reoccur within a few days.

Side Effects

For external use only. Patients should discontinue use if the condition worsens, if symptoms persist for more than 7 days, or if symptoms clear up and then reoccur within a few days. It is advised that patients consult a doctor under the same circumstances: if the condition worsens, if symptoms persist for more than 7 days, or if symptoms clear up and then reoccur again within a few days.

Drug Interactions

There are no reported drug interactions associated with the use of this medication. Additionally, no interactions with laboratory tests have been identified. Therefore, no dosage adjustments or monitoring recommendations are necessary based on drug interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Tidl Full Body Pain Relief Cryotherapy Spray. (full body pain relief cryotherapy spray.). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 12 years of age should consult a physician prior to use. For adolescents and children aged 12 years and older, the recommended dosage is to apply the medication to the affected area no more than 3 to 4 times daily.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

There is no information available regarding the use of this drug during pregnancy, including safety concerns, dosage modifications, or any special precautions that should be taken. Healthcare professionals are advised to consider the lack of data when prescribing this medication to pregnant patients and to weigh the potential risks and benefits. Women of childbearing potential should be counseled accordingly.

Lactation

Nursing mothers should consult a physician before using this product. There is a potential for excretion in breast milk, and the effects on a nursing infant are not well studied; therefore, caution is advised.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the prescribing information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should implement supportive care measures, which may include monitoring vital signs, providing symptomatic treatment, and ensuring the patient's safety.

If available, consultation with a poison control center or a medical toxicologist is recommended to guide the management of the overdose effectively. Additionally, healthcare professionals should refer to local protocols and guidelines for the management of overdose situations, as these may provide specific recommendations based on the substance involved.

Overall, vigilance and prompt intervention are critical in managing any suspected overdose scenario.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data in these areas limits the understanding of the compound's potential effects in nonclinical settings.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Patients should be advised to seek immediate medical assistance or contact a Poison Control Center if the product is accidentally ingested. It is important to inform patients to avoid using the product while smoking or in proximity to heat or open flames, as this may pose safety risks.

Healthcare providers should counsel patients to monitor their condition closely. If symptoms worsen, persist for more than 7 days, or if symptoms clear up and then reoccur within a few days, patients should be instructed to consult their healthcare provider.

Patients must be cautioned to avoid contact with the eyes or mucous membranes, as this may lead to irritation or adverse effects. Additionally, they should not apply the product to wounds, damaged skin, or irritated skin to prevent further complications.

It is essential to inform patients not to bandage the area after application, as this may interfere with the product's effectiveness. After using the product, patients should wash their hands thoroughly with cool water to ensure that any residue is removed.

Finally, patients should be advised against using the product in conjunction with a heating pad or any heating device, as this may lead to increased risk of adverse reactions.

Storage and Handling

The product is supplied in a container that must be kept tightly closed to maintain its integrity. It should be stored at room temperature, away from direct light exposure to protect its quality. Once opened, the product should be discarded to ensure safety and efficacy.

Additional Clinical Information

The medication is administered topically, with a recommended application frequency of 3 to 4 times daily for adults and children aged 12 years and older. For children under 12 years of age, it is advised to consult a physician prior to use. There is no additional information available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Tidl Full Body Pain Relief Cryotherapy Spray., including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)